Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The National Center for Natural Products Research (NCNPR) at 30: A Legacy of Pioneering Research in Natural Products and Dietary Supplements.

Journal of dietary supplements·2024
Same author

Human quad liver-on-chip system as a tool toward bridging the gap between animals and humans regarding toxicology and pharmacology of a cannabidiol-rich cannabis extract.

Drug and chemical toxicology·2024
Same author

Inter-strain variability in responses to a single administration of the cannabidiol-rich cannabis extract in mice.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2024
Same author

Primaquine-5,6-Orthoquinone Is Directly Hemolytic to Older G6PD Deficient RBCs in a Humanized Mouse Model.

The Journal of pharmacology and experimental therapeutics·2024
Same author

Population pharmacokinetics of primaquine and its metabolites in African males.

Malaria journal·2024
Same author

Juniper Berries Regulate Diabetes and Obesity Markers Through Modulating PPAR<i>α</i>, PPAR<i>γ</i>, and LXR: <i>In Vitro</i> and <i>In Vivo</i> Effects.

Journal of medicinal food·2023
Same journal

Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

The American journal of medicine·2026
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric panniculitis.

The American journal of medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements
08:54

NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements

Published on: May 1, 2017

How physicians should evaluate dietary supplements.

James K Glisson1, Larry A Walker

  • 1Department of Internal Medicine, University of Mississippi Medical Center, Jackson, Miss 39216, USA. JKGlisson@medicine.umsmed.edu

The American Journal of Medicine
|May 25, 2010
PubMed
Summary
This summary is machine-generated.

Dietary supplements are widely used as complementary therapies, but their safety and effectiveness are often assumed rather than proven. Clinicians need practical guidance for evaluating these products due to limited data and inconsistent quality.

Related Experiment Videos

Last Updated: Jun 12, 2026

NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements
08:54

NMR Spectroscopy as a Robust Tool for the Rapid Evaluation of the Lipid Profile of Fish Oil Supplements

Published on: May 1, 2017

Area of Science:

  • Integrative Medicine
  • Pharmacology
  • Clinical Practice

Background:

  • Dietary supplements are frequently used by patients without medical supervision.
  • Regulatory oversight and quality control for supplements differ significantly from medications.
  • Misconceptions regarding the safety and efficacy of dietary supplements are common among patients and healthcare providers.

Purpose of the Study:

  • To clarify issues surrounding the evaluation of dietary supplements.
  • To provide practical recommendations for clinicians advising patients on supplement use.
  • To address the challenges posed by limited and variable data on supplement quality and effects.

Main Methods:

  • Review of existing literature on dietary supplement pharmacodynamics and pharmacokinetics.
  • Analysis of regulatory status and labeling laws for dietary supplements.
  • Evaluation of the quality and characterization of supplements used in clinical studies.

Main Results:

  • Historically, data on dietary supplement pharmacodynamics and pharmacokinetics are limited and of poor quality.
  • Non-medical literature is often unreliable; even medical studies may use poorly characterized products.
  • Despite increased focus, significant challenges remain in assessing supplement integrity and advising patients.

Conclusions:

  • Clinicians face challenges due to the unregulated nature and variable quality of dietary supplements.
  • Practical strategies are needed to help healthcare providers evaluate supplement literature and guide patient choices.
  • Addressing data limitations and product variability is crucial for safe and effective complementary therapy integration.